CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SMS PHARMACEUTICALS LTD.

NSE : SMSPHARMABSE : 532815ISIN CODE : INE812G01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE462.0042.85 (+10.22 %)
PREV CLOSE () 419.15
OPEN PRICE () 412.55
BID PRICE (QTY) 461.50 (256)
OFFER PRICE (QTY) 462.40 (217)
VOLUME 405134
TODAY'S LOW / HIGH ()412.55 466.85
52 WK LOW / HIGH ()240.45 446.5
NSE460.2542.8 (+10.25 %)
PREV CLOSE() 417.45
OPEN PRICE () 417.85
BID PRICE (QTY) 460.25 (24)
OFFER PRICE (QTY) 460.30 (136)
VOLUME 9560156
TODAY'S LOW / HIGH() 414.55 467.00
52 WK LOW / HIGH ()242.25 447.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987

Management Info :

Ramesh Babu Potluri - Chairman Ramesh Babu Potluri - Managing Director

Registered Office :

Address : 8th Floor, Trendset Jayabheri Connect,Kondapur ,Serilingampally, Rangareddy Dist.,
Hyderabad,
Telangana-500084

Phone : 040 25259999

Website : www.smspharma.com

Registrar's Details : Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE
NEWS
05Sep SMS Pharmaceuticals informs about news
Pursuant to Regulations 30 and 47 of Securities and Exchange Board of In..
02Sep SMS Pharmaceuticals informs about cre
Pursuant to 30 read with Schedule III of SEBI (Listing Obligations and D..
29Aug SMS Pharmaceuticals informs about pres
SMS Pharmaceuticals has informed that it enclosed copies of the newspape..
27Aug SMS Pharmaceuticals informs about AGM
SMS Pharmaceuticals has informed that due to certain unavoidable circums..
25Jul SMS Pharmaceuticals informs about boar
SMS Pharmaceuticals has informed that the meeting of the Board of Direct..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit211.31876.1
Gross Profit 281.43 1162.72
Operating Profit 436.341792.67
Net Sales 2069.658868.71
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25530.00 (1.02%)
M.Cap ( in Cr)
54249.47
Onesource Specialty (BSE)
 1600.00 (3.53%)
M.Cap ( in Cr)
18389.52
Torrent Pharma (BSE)
 4975.10 (0.95%)
M.Cap ( in Cr)
189012.40
Laurus Labs (BSE)
 1971.35 (1.83%)
M.Cap ( in Cr)
106441.51
Akums Drugs & Pharma (BSE)
 783.45 (4.45%)
M.Cap ( in Cr)
12322.38
Shareholding Pattern
PROMOTERS 68.07%
NON-INSTITUTION 28.45%
MUTUAL FUNDS/UTI 2.81%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74790.49-112.10 (-0.15%)
NIFTY23422.75-55.05 (-0.23%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI